1. Home
  2. UAMY vs PMN Comparison

UAMY vs PMN Comparison

Compare UAMY & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UAMY
  • PMN
  • Stock Information
  • Founded
  • UAMY 1968
  • PMN 2004
  • Country
  • UAMY United States
  • PMN Canada
  • Employees
  • UAMY N/A
  • PMN N/A
  • Industry
  • UAMY Metal Fabrications
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • UAMY Industrials
  • PMN Health Care
  • Exchange
  • UAMY Nasdaq
  • PMN Nasdaq
  • Market Cap
  • UAMY 36.9M
  • PMN 42.7M
  • IPO Year
  • UAMY N/A
  • PMN N/A
  • Fundamental
  • Price
  • UAMY $0.32
  • PMN $2.15
  • Analyst Decision
  • UAMY
  • PMN Strong Buy
  • Analyst Count
  • UAMY 0
  • PMN 1
  • Target Price
  • UAMY N/A
  • PMN $8.00
  • AVG Volume (30 Days)
  • UAMY 212.0K
  • PMN 9.4K
  • Earning Date
  • UAMY 05-14-2024
  • PMN 08-12-2024
  • Dividend Yield
  • UAMY N/A
  • PMN N/A
  • EPS Growth
  • UAMY N/A
  • PMN N/A
  • EPS
  • UAMY N/A
  • PMN N/A
  • Revenue
  • UAMY $9,313,701.00
  • PMN N/A
  • Revenue This Year
  • UAMY N/A
  • PMN N/A
  • Revenue Next Year
  • UAMY N/A
  • PMN N/A
  • P/E Ratio
  • UAMY N/A
  • PMN N/A
  • Revenue Growth
  • UAMY N/A
  • PMN N/A
  • 52 Week Low
  • UAMY $0.17
  • PMN $0.95
  • 52 Week High
  • UAMY $0.48
  • PMN $5.77
  • Technical
  • Relative Strength Index (RSI)
  • UAMY 50.12
  • PMN 62.25
  • Support Level
  • UAMY $0.27
  • PMN $1.51
  • Resistance Level
  • UAMY $0.35
  • PMN $2.28
  • Average True Range (ATR)
  • UAMY 0.02
  • PMN 0.17
  • MACD
  • UAMY -0.00
  • PMN 0.06
  • Stochastic Oscillator
  • UAMY 61.75
  • PMN 76.30

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: